Fingerprint
Dive into the research topics of 'Benefits of high-dose, high-frequency interferon beta-1a in relapsing-remitting multiple sclerosis are sustained to 16 months: Final comparative results of the EVIDENCE trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically